Provided by Tiger Trade Technology Pte. Ltd.

Zura Bio

6.01
+0.34006.00%
Post-market: 6.010.00000.00%19:07 EST
Volume:452.13K
Turnover:2.66M
Market Cap:390.79M
PE:-8.96
High:6.11
Open:5.72
Low:5.59
Close:5.67
52wk High:6.63
52wk Low:0.9700
Shares:65.02M
Float Shares:24.68M
Volume Ratio:1.06
T/O Rate:1.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6709
EPS(LYR):-0.6046
ROE:-45.01%
ROA:-27.24%
PB:3.61
PE(LYR):-9.94

Loading ...

Zura Bio nimmt am Guggenheim Emerging Outlook: Biotech Summit in New York teil

Reuters
·
Feb 04

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jan 31

Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for Director Parvinder Thiara

Reuters
·
Jan 28

Zura Bio Names Sandeep Kulkarni CEO

Reuters
·
Jan 26

BRIEF-Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. As CEO

Reuters
·
Jan 21

Zura Bio Names Sandeep Kulkarni CEO as Robert Lisicki Resigns

Reuters
·
Jan 21

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.d. as Chief Executive Officer

THOMSON REUTERS
·
Jan 21

Zura Bio Ltd - Robert Lisicki Resigns as CEO and Director

THOMSON REUTERS
·
Jan 21

Zura Bio Projects Cash Runway Through 2027

Reuters
·
Jan 12

Zura Bio Reports Business Updates and Outlook for 2026

THOMSON REUTERS
·
Jan 12

Zura Bio Ltd - Expects Clinical Validation of Tibulizumab in Hs in 2026

THOMSON REUTERS
·
Jan 12

Zura Bio Ltd - Topline Data From Tibushield Trial Expected in Q4 2026

THOMSON REUTERS
·
Jan 12

Zura Bio Ltd - Expects Cash to Fund Operations Through 2027

THOMSON REUTERS
·
Jan 12

BRIEF-Zura Bio Ltd - On Dec 29, Co And Units Entered Into Several Agreements

Reuters
·
Jan 03

Zura Bio Ltd - on Dec 29, Co and Units Entered Into Several Agreements Which Were Determined to Be More Commercially Advantageous to Co - SEC Filing

THOMSON REUTERS
·
Jan 03

Zura Bio Issues 8.7 Million Shares to Athanor in Private Placement

Reuters
·
Jan 03

Zura Bio Director Arnout Ploos van Amstel Resigns

Reuters
·
Dec 17, 2025

December 2025's Top Penny Stocks With Promising Potential

Simply Wall St.
·
Dec 16, 2025

Zura Bio Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 15, 2025

Zura Bio Q4 EPS $(0.21) Misses $(0.18) Estimate

Benzinga
·
Nov 13, 2025